Takip et
Henning Reis, MD
Henning Reis, MD
Inst. of Pathology, University Hospital Frankfurt
uk-essen.de üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus …
KJ Schmitz, J Wohlschlaeger, H Lang, GC Sotiropoulos, M Malago, ...
Journal of hepatology 48 (1), 83-90, 2008
3742008
Clinical, prognostic, and therapeutic aspects of urachal carcinoma—a comprehensive review with meta-analysis of 1,010 cases
T Szarvas, O Módos, C Niedworok, H Reis, A Szendröi, MA Szász, ...
Urologic Oncology: Seminars and Original Investigations 34 (9), 388-398, 2016
1862016
Prognostic value of tissue and circulating levels of IMP3 in prostate cancer
T Szarvas, S Tschirdewahn, C Niedworok, G Kramer, S Sevcenco, H Reis, ...
International journal of cancer 135 (7), 1596-1604, 2014
1762014
Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT
P Heusch, C Buchbender, J Köhler, F Nensa, T Gauler, B Gomez, H Reis, ...
Journal of Nuclear Medicine 55 (3), 373-378, 2014
1322014
Tumor markers as a diagnostic key for hilar cholangiocarcinoma
B Juntermanns, S Radunz, M Heuer, S Hertel, H Reis, JP Neuhaus, ...
European Journal of Medical Research 15, 357-361, 2010
1112010
Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer
A Eyking, B Ey, M Rünzi, AI Roig, H Reis, KW Schmid, G Gerken, ...
Gastroenterology 141 (6), 2154-2165, 2011
1052011
SF3B1 and BAP1 mutations in blue nevus-like melanoma
KG Griewank, H Müller, LA Jackett, M Emberger, I Möller, ...
Modern Pathology 30 (7), 928-939, 2017
992017
AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma
KJ Schmitz, H Lang, J Wohlschlaeger, GC Sotiropoulos, H Reis, ...
World journal of gastroenterology: WJG 13 (48), 6470, 2007
962007
PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: concordance among 3 commonly used and commercially available antibodies
H Reis, R Serrette, J Posada, V Lu, Y Chen, A Gopalan, SW Fine, ...
The American journal of surgical pathology 43 (7), 920-927, 2019
832019
NF1 mutations in conjunctival melanoma
SL Scholz, I Cosgarea, D Süßkind, R Murali, I Möller, H Reis, ...
British Journal of Cancer 118 (9), 1243-1247, 2018
822018
MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancer
A Eyking, H Reis, M Frank, G Gerken, KW Schmid, E Cario
PloS one 11 (6), e0156871, 2016
782016
MET expression in advanced non–small-cell lung cancer: effect on clinical outcomes of chemotherapy, targeted therapy, and immunotherapy
H Reis, M Metzenmacher, M Goetz, N Savvidou, K Darwiche, C Aigner, ...
Clinical lung cancer 19 (4), e441-e463, 2018
762018
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology
P Heusch, F Nensa, B Schaarschmidt, R Sivanesapillai, K Beiderwellen, ...
European journal of nuclear medicine and molecular imaging 42, 42-48, 2015
762015
Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
M Wiesweg, S Kasper, K Worm, T Herold, H Reis, L Sara, ...
Oncogene 38 (16), 2953-2966, 2019
752019
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
C Franklin, I Rooms, M Fiedler, H Reis, L Milsch, S Herz, E Livingstone, ...
European Journal of Cancer 86, 248-256, 2017
722017
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma
J Padden, DA Megger, T Bracht, H Reis, M Ahrens, M Kohl, M Eisenacher, ...
Molecular & Cellular Proteomics 13 (10), 2661-2672, 2014
722014
Treatment outcome of atypical EGFR mutations in the German national network genomic medicine lung cancer (nNGM)
M Janning, J Süptitz, C Albers-Leischner, P Delpy, A Tufman, ...
Annals of oncology 33 (6), 602-615, 2022
702022
High prevalence of concomitant oncogene mutations in prospectively identified patients with ROS1-positive metastatic lung cancer
M Wiesweg, WEE Eberhardt, H Reis, S Ting, N Savvidou, C Skiba, ...
Journal of Thoracic Oncology 12 (1), 54-64, 2017
702017
Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging/transrectal ultrasonography–fusion biopsy
S Tschirdewahn, M Wiesenfarth, D Bonekamp, L Püllen, H Reis, A Panic, ...
European urology focus 7 (6), 1300-1307, 2021
692021
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer
T Szarvas, H Reis, G Kramer, SF Shariat, F Vom Dorp, S Tschirdewahn, ...
Human pathology 45 (4), 674-682, 2014
682014
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20